173 related articles for article (PubMed ID: 1850101)
1. Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity.
Faaland CA; Mermelstein FH; Hayashi J; Laskin JD
Mol Cell Biol; 1991 May; 11(5):2697-703. PubMed ID: 1850101
[TBL] [Abstract][Full Text] [Related]
2. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities.
Nowak F; Jacquemin-Sablon A; Pierre J
Biochem Pharmacol; 1997 Feb; 53(3):287-98. PubMed ID: 9065732
[TBL] [Abstract][Full Text] [Related]
4. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation.
Lyall RM; Zilberstein A; Gazit A; Gilon C; Levitzki A; Schlessinger J
J Biol Chem; 1989 Aug; 264(24):14503-9. PubMed ID: 2788167
[TBL] [Abstract][Full Text] [Related]
5. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation.
Miller CC; Hale P; Pentland AP
J Biol Chem; 1994 Feb; 269(5):3529-33. PubMed ID: 8106395
[TBL] [Abstract][Full Text] [Related]
7. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
Fan Z; Lu Y; Wu X; DeBlasio A; Koff A; Mendelsohn J
J Cell Biol; 1995 Oct; 131(1):235-42. PubMed ID: 7559780
[TBL] [Abstract][Full Text] [Related]
8. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
Gazit A; Yaish P; Gilon C; Levitzki A
J Med Chem; 1989 Oct; 32(10):2344-52. PubMed ID: 2552117
[TBL] [Abstract][Full Text] [Related]
9. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.
Hoffman R; Dennis IF; Donaldson J
Cancer Chemother Pharmacol; 1995; 36(4):316-24. PubMed ID: 7628051
[TBL] [Abstract][Full Text] [Related]
10. Activation of the mitogen-activated protein kinase cascade by tyrphostin (RG 50864).
Agbotounou WK; Mousset S; Piperno S; Pierre M; Jacquemin-Sablon A; Pierre J
Biochem Pharmacol; 1994 Aug; 48(3):505-15. PubMed ID: 8068037
[TBL] [Abstract][Full Text] [Related]
11. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation.
Peterson G; Barnes S
Prostate; 1993; 22(4):335-45. PubMed ID: 8497428
[TBL] [Abstract][Full Text] [Related]
12. Tyrphostins inhibit the epidermal growth factor receptor-mediated breakdown of phosphoinositides.
Posner I; Gazit A; Gilon C; Levitzki A
FEBS Lett; 1989 Nov; 257(2):287-91. PubMed ID: 2555218
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
Dvir A; Milner Y; Chomsky O; Gilon C; Gazit A; Levitzki A
J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle.
Yang SG; Saifeddine M; Hollenberg MD
Can J Physiol Pharmacol; 1992 Jan; 70(1):85-93. PubMed ID: 1316219
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-specific protein tyrosine phosphorylation in preimplantation embryo development.
Paria BC; Tsukamura H; Dey SK
Biol Reprod; 1991 Nov; 45(5):711-8. PubMed ID: 1721842
[TBL] [Abstract][Full Text] [Related]
16. Effect of tyrosine kinase inhibition on surfactant protein A gene expression during human lung development.
Klein JM; DeWild LJ; McCarthy TA
Am J Physiol; 1998 Apr; 274(4 Pt 1):L542-51. PubMed ID: 9575872
[TBL] [Abstract][Full Text] [Related]
17. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation.
Soltoff SP
J Biol Chem; 1998 Sep; 273(36):23110-7. PubMed ID: 9722539
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
Klein JM; McCarthy TA
Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein-tyrosine kinases by tyrphostins.
Levitzki A; Gazit A; Osherov N; Posner I; Gilon C
Methods Enzymol; 1991; 201():347-61. PubMed ID: 1658552
[No Abstract] [Full Text] [Related]
20. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
